Your patient is receiving basiliximab and develops cytokine release syndrome. You would expect to see:

Correct Answer: B

Rationale: Basiliximab is a monoclonal antibody that can cause cytokine release syndrome, characterized by flu-like symptoms such as chills. This occurs due to the rapid release of cytokines in response to the antibody, leading to systemic inflammatory response. Coughing, tremors, and weakness are not typically associated with cytokine release syndrome. Therefore, the correct answer is B (Chills).

Correct Answer: A

Rationale: The correct answer is A because providing the patient with a vaccine information statement in their primary language is crucial for informed consent and ensuring the patient understands the vaccine they received. This helps in addressing any concerns or questions the patient may have. B is incorrect because determining the exact date of the patient's last tetanus booster is important but not as immediate as providing vaccine information to the patient. C is incorrect because documenting side effects is important but not the most immediate action required after administering the vaccine. D is incorrect because providing the patient with a record of the immunization is also important but not as critical as ensuring the patient receives information about the vaccine they just received.

Correct Answer: D

Rationale: The correct answer is D because it is crucial for the patient to understand the importance of completing the full HPV vaccination series for optimal protection. By informing the patient about the date for the next dose, it ensures adherence to the recommended schedule and maximizes the effectiveness of the vaccine. This helps in building long-term immunity against HPV-related diseases. Choice A is incorrect because HPV vaccination does not prevent all sexually transmitted diseases, it specifically targets HPV strains. Choice B is incorrect because even after HPV vaccination, regular Pap smears are still necessary for cervical cancer screening. Choice C is incorrect as mild pain at the injection site is a common side effect of the vaccine and does not typically require notification to the healthcare provider unless it persists or worsens.

Correct Answer: C

Rationale: Rationale for Correct Answer (C): The nurse should instruct the patient to increase fluid intake while taking interferon alfa 2b because this medication can lead to dehydration as a side effect. Increasing fluid intake can help prevent dehydration and support overall well-being during treatment. Dehydration can worsen side effects and impact treatment efficacy. Summary of Incorrect Choices: A: Avoid drinking alcohol while taking the drug - While it is generally advisable to limit alcohol consumption during medical treatment, there is no specific interaction between interferon alfa 2b and alcohol mentioned in the question. B: Continue to maintain maximal physical activity - This choice is not directly related to the medication instructions provided in the question. Excessive physical activity may not always be appropriate for patients undergoing leukemia treatment. D: Treat constipation with over-the-counter laxatives - Constipation is not a common side effect associated with interferon alfa 2b, so using laxatives may not be necessary unless specifically recommended by a healthcare provider.

Correct Answer: B

Rationale: The correct answer is B: The need to use barrier contraceptives while taking the drug. This is important because immune modulators can have teratogenic effects, meaning they can harm a developing fetus. Using barrier contraceptives can help prevent pregnancy and protect the fetus from potential harm. Choice A is incorrect because continuing oral contraceptives may not provide adequate protection against pregnancy while on immune modulators. Choice C is incorrect as avoiding sexual intercourse is not necessary as long as effective contraception is used. Choice D is incorrect as taking aspirin daily is not related to the use of immune modulators and may not decrease adverse effects.